Free T4 blood test
Free thyroxine (free T4). Also called: FT4, Free thyroxine, Thyroxine, free, T4, free
Free T4 is the unbound thyroxine in your blood, the part available to tissues. Labcorp prints 0.82-1.77 ng/dL and Quest 0.8-1.8 ng/dL for adults. It is read together with TSH: TSH first, free T4 to tell how far thyroid function is off.
Not part of a standard Thyroid Panel, which estimates free T4 from total T4 and T3 uptake. Free T4 is ordered on its own or with TSH.
At a glance
| What it measures | The thyroxine (T4) in blood that is not bound to carrier proteins: the small fraction available to tissues. |
|---|---|
| Sample | Serum (preferred) or plasma. Stop high-dose biotin at least 72 hours before; not during or soon after heparin. |
| Adult ranges | Labcorp 0.82-1.77 ng/dL (over 19 years); Quest 0.8-1.8 ng/dL (over 20 years); Quest by dialysis 0.9-2.2 ng/dL. |
| Peptides that move it | Lowered toward normal by Octreotide and Lanreotide in TSH-secreting pituitary tumors; raised by Thyrotropin-Releasing Hormone (TRH). Semaglutide tablets raise levothyroxine absorption. |
| Lab code | LOINC 3024-7 (Labcorp 001974, Quest 866); 6892-4 by dialysis (Quest 35167) |
What is Free T4?
Thyroxine (T4) is the main hormone the thyroid releases. Almost all of it travels bound to carrier proteins; free T4 is the small unbound part that can enter cells, where it is converted to the more active T3. Free T4 has largely replaced total T4 testing because it is less affected by the level of binding proteins. It is usually ordered with TSH, or after an abnormal TSH.
How it is made and regulated
Where it is made
The thyroid makes T4 when the pituitary hormone TSH stimulates it. TSH in turn is driven by thyrotropin-releasing hormone (TRH) from the hypothalamus, which is why Thyrotropin-Releasing Hormone (TRH) raises T4.
What controls it
Free T4 feeds back on the pituitary: when it falls, TSH rises, and when it rises, TSH falls. In central hypothyroidism the pituitary or hypothalamus fails, so free T4 is low while TSH is inappropriately low or normal.
How it travels in the blood
Most T4 is bound to thyroxine-binding globulin and other proteins. Free T4 should be normal in euthyroid people with high binding globulin and in familial dysalbuminemic hyperthyroxinemia. When binding proteins are very abnormal, an equilibrium-dialysis test (Quest 35167) is more reliable than the usual immunoassay.
How long it lasts
T4 changes slowly. Levothyroxine reaches steady state about 4-6 weeks after a dose change, which is when guidelines recheck TSH; free T4 can be used to assess a dose change sooner than the 6-8 weeks TSH needs to settle.
What it does
T4 is converted to T3, the active hormone, in tissues outside the thyroid, a process first shown in people without a thyroid. Growth hormone speeds this conversion, so free T4 can dip slightly as free T3 rises on growth hormone therapy.
Reference ranges
Adult ranges are close at the two labs. Children have their own age bands, and the only pregnancy ranges either lab prints are on Quest's dialysis test. Methods differ, so compare results from the same lab and method.
Labcorp (test 001974)
| Group | Range (ng/dL) |
|---|---|
| Over 19 years | 0.82-1.77 |
Children and teens
| Group | Range (ng/dL) |
|---|---|
| 0 to 3 days | 0.66-2.71 |
| 4 to 30 days | 0.83-3.09 |
| 31 days to 12 months | 0.48-2.34 |
| 13 months to 5 years | 0.85-1.75 |
| 6 to 10 years | 0.90-1.67 |
| 11 to 19 years | 0.93-1.60 |
As printed on Labcorp's test page for 001974. No pregnancy range is printed.
Quest Diagnostics (test 866)
| Group | Range (ng/dL) |
|---|---|
| Over 20 years | 0.8-1.8 |
Children and teens
| Group | Range (ng/dL) |
|---|---|
| 1-23 months | 0.9-1.4 |
| 2-12 years | 0.9-1.4 |
| 13-20 years | 0.8-1.4 |
From Quest's test directory. Quest gives no range for babies under 1 month and no pregnancy range for this test.
Quest Diagnostics (test 35167)
| Group | Range (ng/dL) |
|---|---|
| Adults | 0.9-2.2 |
| Pregnancy, first trimester | 0.9-2.0 |
| Pregnancy, second trimester | 0.8-1.5 |
| Pregnancy, third trimester | 0.8-1.7 |
Children and teens
| Group | Range (ng/dL) |
|---|---|
| Birth to 4 days | 2.2-5.3 |
| 2 months to 2 years | 1.2-2.5 |
| 3 to 17 years | 1.0-2.4 |
Quest's direct-dialysis test, used when binding proteins are very abnormal. Quest also prints ranges for premature babies and cord blood.
Labcorp notes that free T4 results differ between methods. Quest's dialysis test reads higher than its standard immunoassay and is the one with trimester-specific pregnancy ranges.
Units: Labs outside the US report free T4 in pmol/L. Multiply pmol/L by 0.077688 to get ng/dL. [12]
Is there an "optimal" range?
There is no single "optimal" free T4. Results depend on the method, change with age, and on treatment the target depends on why the thyroid is underactive.
The lab interval
Labcorp 0.82-1.77; Quest 0.8-1.8 ng/dL
Labcorp 001974 and Quest 866
The adult ranges the two labs print for their immunoassays.
Method matters
Quest dialysis 0.9-2.2 ng/dL
Quest 35167; Labcorp
Dialysis reads higher than the analog immunoassay, and Labcorp notes that free T4 results differ between methods.
Age-specific limits
Upper limit rises from age 70
Jansen and colleagues (2024); Bi and colleagues (2025)
In 2.2 million free T4 requests from 13 Dutch laboratories the upper limit increased from 70 years onward, and a study of 1,862,273 dialysis results found a mild increase in older adults.
A treatment target in central hypothyroidism
Upper half of the range
American Thyroid Association (2014)
When TSH cannot be used, as in secondary hypothyroidism, the goal is free T4 in the upper half of the range, lower in older people or those with other illnesses (strong recommendation).
Sources: [8]
What raises it
| Factor | How | How much |
|---|---|---|
| Overactive thyroidCondition | Graves disease and toxic nodules release too much T4; free T4 is usually high in hyperthyroidism. | No published magnitude [1] [15] |
| Some medicines and contrastMedication | Labcorp lists radiologic contrast agents, propranolol, amiodarone and heparin as raising free T4. | No published magnitude [2] |
| Nonthyroidal illnessCondition | Free T4 can rise transiently in illnesses outside the thyroid. | No published magnitude [2] |
| Assay interferencePhysiology | Antibodies against thyroid hormones and high-dose biotin can give falsely high results that mimic Graves disease. | No published magnitude [12] [2] |
| TRHPeptide | Thyrotropin-Releasing Hormone (TRH) drives TSH, which pushes T4 up. | Free T4 index +68% on continuous TRH for 4-7 months [5] |
| Levothyroxine taken with semaglutide tabletsMedication | Semaglutide tablets increase how much levothyroxine is absorbed, so the label advises monitoring thyroid tests. | Total thyroxine AUC +33% after a single levothyroxine dose [16] |
What lowers it
| Factor | How | How much |
|---|---|---|
| Underactive thyroidCondition | In hypothyroidism free T4 is low; with a high TSH it is overt primary hypothyroidism. | No published magnitude [1] [17] |
| Pituitary or hypothalamic diseaseCondition | Central hypothyroidism gives a low free T4 with an inappropriately low or normal TSH. | No published magnitude [7] |
| Growth hormone therapyHormone | Growth hormone speeds T4-to-T3 conversion; starting it can unmask central hypothyroidism in people with pituitary disease. | Free T4 -1.09 ± 1.99 pmol/l in hypopituitary men [18] [7] |
| Carbamazepine and severe illnessMedication | Labcorp lists carbamazepine as lowering free T4, and low values are reported in nonthyroidal illness. | No published magnitude [2] |
| Somatostatin analogsPeptide | Octreotide and Lanreotide suppress TSH; in TSH-secreting pituitary tumors they bring high free T4 down. | 37.9 to 19.7 pmol/L on lanreotide over 6 months [19] [20] |
Peptides that affect Free T4
How each peptide in our library has been shown to change free T4, strongest evidence first. Rows marked total T4 measured total thyroxine rather than free T4. Somatostatin analogs lower it in TSH-secreting pituitary tumors; Exenatide and Liraglutide did not change it in before-after studies, a Semaglutide chart review is unclear, and semaglutide tablets raise how much levothyroxine is absorbed. A thyroid hormone test does not screen for the medullary thyroid cancer in the GLP-1 drug warnings (see the FAQ). No study has reported free T4 after dosing Tirzepatide, Retatrutide, Dulaglutide, Lixisenatide, Tesamorelin, CJC-1295, Ipamorelin, Mod GRF 1-29, Pasireotide or IGF-1 LR3 in people; PubMed searches for each find no human dosing data (for tirzepatide only case reports, and the GHRP-2 data come from infusions given together with TRH). The melanocortin peptides, BPC-157, TB-500 and the rest of our library have no human free T4 data either.
| Peptide | Measured | Effect on Free T4 | Size of effect | Evidence |
|---|---|---|---|---|
| Ghrelin | Free T4 | Raises | 20 healthy adults, 50 micrograms at 2200, 2300, 0000 and 0100 h vs placebo (acute, crossover): free T4 AUC 1.39 vs 1.31 ng/dl x min (P=0.001), while TSH fellA small overnight rise in free T4 in one crossover study, with a larger fall in TSH. [21] | Human trials |
| LeptinWomen with hypothalamic amenorrhea (low leptin) | Free T4 | Raises | No figure in the abstract: in eight women with hypothalamic amenorrhea treated with recombinant leptin for up to three months, free thyroxine rose significantly (six untreated controls did not change)Replacing leptin where it is abnormally low raised free T4. [22] | Human trials |
| Macimorelin | Free T4 | Raises | 28 healthy volunteers, single oral dose of 0.5 and 0.75 mg/kg (acute), sampled to 120 min: free T4 maximal median change 0.5 [0.2; 0.8] pmol/L (p < 0.001) while TSH fellA small, short-lived rise after a single test dose. [23] | Human trials |
| Thyrotropin-Releasing Hormone (TRH) | Free T4 | Raises | Four people with ALS on continuous intrathecal or epidural TRH for 4-7 months (sustained): free T4 index +68% and serum T4 +49%, means near the upper limit of normal. 17 healthy volunteers, single oral dose of 40 mg (acute): total and free T4 peaked at 360 minTRH stimulates TSH, which pushes T4 up; sustained infusions kept it near the top of the normal range. [5] [6] | Human trials |
| Adrenocorticotropic Hormone (ACTH) | Total T4 | Lowers | Single IM dose of synthetic ACTH 1 mg in 38 hospitalized patients with acute gout (acute): total T4 decreased at 24 and 48 h. ACTH loading in normal subjects: serum T4 decreased for 2 to 4 days. Free T4 was not reportedShort ACTH courses lower total T4 for a few days, via the cortisol surge. [24] [25] | Human trials |
| LanreotideTSH-secreting pituitary tumors | Free T4 | Lowers | 18 patients with TSH-secreting adenomas, slow-release lanreotide 30 mg every 10-14 days for 6 months: free T4 37.9 to 19.7 pmol/L (P < 0.01)Lanreotide roughly halved high free T4 in TSH-secreting tumors. [19] [26] | Human trials |
| OctreotideTSH-secreting pituitary tumors | Free T4 | Lowers | Five patients with TSH-secreting tumors, 100 micrograms three times daily for 5 days: TSH fell 86% on average with normalization of free T4. Octreotide-LAR 30 mg every 28 days for two months: free T4 normalized or fell more than 30% in 7 of 8 patientsIn TSH-secreting tumors octreotide brings high free T4 back to normal. [27] [28] | Human trials |
| Exenatide | Free T4 | No clear effect | Type 2 diabetes without thyroid disease, 6 months (46 enrolled, 13 excluded): free T4 not significantly different, while TSH fell 2.3 to 1.8 mIU/L. 112 people with type 2 diabetes and obesity, 12 months: no change in free T4Free T4 held steady in three before-after studies even though TSH fell. [29] [30] [31] | Human trials |
| Hexarelin | Free T4 | No clear effect | 12 subjects (ten children with familial short stature, two adults), hexarelin 1 microgram/kg IV and 20 micrograms/kg intranasally (acute): no significant change in free T4, although TSH fellSingle doses only. [32] | Human trials |
| Human Chorionic Gonadotropin (hCG) | Free T4 | No clear effect | Measured, no change: hCG given to trigger ovulation during ovarian hyperstimulation produced lower hCG levels than pregnancy and failed to alter free thyroxine or TSH (p > 0.22)A fertility-treatment dose of hCG did not change free T4 or TSH. [33] | Human trials |
| IGF-1 (Insulin-Like Growth Factor 1) | Total T4 | No clear effect | 10 children with short stature, single IV dose of recombinant IGF-I 5 micrograms/kg (acute): serum T4 not modified, though TSH fell. Free T4 was not reportedOne single-dose study; free T4 not reported. [34] | Human trials |
| LeptinOverweight or obesity on a diet | Free T4 | No clear effect | Measured, no difference: 24 overweight and obese adults on a mild hypocaloric diet, metreleptin 10 mg/day vs placebo for 6 months (sustained); free T4 fell with diet-induced weight loss, but changes in thyroid hormones were not significantly different between the groupsFree T4 fell with weight loss whether or not people took leptin. [35] | Human trials |
| Leuprolide | Free T4 | No clear effect | 73 girls with central precocious puberty, monthly leuprorelin or triptorelin depots for 40.4 months: no difference in free T4 (free T3 fell). A meta-analysis of 22 studies of GnRH analog treatment found no significant change in free T4Long-term GnRH-agonist treatment in children left free T4 unchanged. [36] [37] | Human trials |
| Liraglutide | Free T4 | No clear effect | 49 overweight or obese adults with type 2 diabetes and fatty liver, liraglutide for an average of 16 months (before-after, no placebo group): free T4 14.17 to 13.24 pmol/L (p = 0.975) while TSH fellNo change in free T4 in one before-after study. [38] | Human trials |
| MK-677 (Ibutamoren) | Total T4 | No clear effect | 18 GH-deficient children, 0.8 mg/kg per day for 8 days: no change in thyroxine. Nine GH-deficient men, 10 or 50 mg/day for 4 days: no significant change in thyroid hormones. Free T4 was not reportedShort courses left thyroxine unchanged; free T4 itself has not been reported. [39] [40] | Human trials |
| Sermorelin | Free T4 | No clear effect | Five normal men, single IV bolus of GHRH(1-29)-NH2 0.015 to 0.5 micrograms/kg (acute): free thyroxine not affectedSingle doses only. [41] | Human trials |
| Somatostatin | Free T4 | No clear effect | 12-hour infusion (250 micrograms bolus, then 500 micrograms/h; acute) in 37 volunteers: no change in T4 or free T4 in normal subjects or in free T4 in hyperthyroid subjectsNative somatostatin infusions did not move free T4. [42] | Human trials |
| Triptorelin | Free T4 | No clear effect | 73 girls with central precocious puberty, monthly leuprorelin or triptorelin depots for 40.4 months: no difference in free T4 (free T3 fell)Long-term treatment in children left free T4 unchanged. [36] | Human trials |
| Erythropoietin (EPO) | Free T4 | Unclear | Hemodialysis with anemia: 22 patients, 6 months of rhEPO 1,500-9,000 U/week: free T4 rose in the 11 whose hematocrit rose more than 5%, not in the other 11. Twenty-four patients, 4 months: free T4 rose significantly. 21 men: no significant changeFree T4 rose in some dialysis studies as anemia improved, not in others. [43] [44] [45] | Human trials |
| Semaglutide | Free T4 | Unclear | No figure in the abstract: in a retrospective chart review of 255 adults on semaglutide for weight management (no control group), T4 rose over follow-up; the paper does not say whether free or total T4 was measuredOne uncontrolled chart review; no trial has reported free T4 on semaglutide. [46] | Human trials |
| LanreotideAcromegaly | Free T4 | Lowers | Label, no free T4 figure: slight decreases in thyroid function have been seen in acromegaly, with clinical hypothyroidism in less than 1%Rare low thyroid function in acromegaly. [47] | FDA label |
| OctreotideOther uses (acromegaly, tumors) | Free T4 | Lowers | Labels: octreotide suppresses TSH and may cause hypothyroidism; check TSH and total and/or free T4 at baseline and periodically. Mycapssa trials: hypothyroidism, increased TSH or decreased free T4 in 1% of patients. Sandostatin in acromegaly: biochemical hypothyroidism in 12%Occasional low thyroid function on long-term use; labels advise periodic thyroid tests. [20] [48] | FDA label |
What high or low results can mean
A high result
Above 1.77 ng/dL at Labcorp or 1.8 at Quest is high. With a low TSH it usually means an overactive thyroid or too much thyroid medicine; with a normal or high TSH, think of assay interference or, rarely, a TSH-secreting pituitary tumor.
- Graves disease or toxic nodules
- Too much thyroid medicine
- Amiodarone, heparin or contrast agents
- Assay interference (biotin, antibodies)
A low result
Below 0.82 ng/dL at Labcorp or 0.8 at Quest is low. With a high TSH it is primary hypothyroidism; with a low or normal TSH it suggests central hypothyroidism from the pituitary or hypothalamus.
- Primary hypothyroidism, often Hashimoto thyroiditis
- Pituitary or hypothalamic disease
- Severe nonthyroidal illness
- Carbamazepine
How the test works
| Sample | Serum (preferred) or plasma, 1 mL at Labcorp, in a red-top, gel-barrier or lithium-heparin tube; not oxalate, EDTA or citrate. |
|---|---|
| Fasting | Labcorp lists no fasting requirement. Do not draw it during or soon after heparin, which affects the assay. |
| Timing | Usually ordered with TSH or after an abnormal TSH. Stop high-dose biotin at least 72 hours before the draw. On levothyroxine, guidelines recheck 4-6 weeks after a dose change. |
| Lab differences | Labcorp uses an ECLIA on the Roche cobas; Quest an immunoassay with a T4 analog. Results differ between methods; equilibrium dialysis (Quest 35167) is the more reliable choice when binding proteins are very abnormal. |
| Retesting | Compare results from the same lab and method. In pregnancy, use trimester-specific ranges where the lab provides them. |
| Labcorp order code | 001974: Thyroxine (T4), Free, Direct |
| Quest Diagnostics order code | 866: T4, Free |
| LOINC codes |
|
History
Free T4 went from a laborious research measurement to a routine automated test in about forty years.
- 1962Sterling and colleagues describe measuring the free thyroxine concentration in human serum. [49]
- 1966Sterling and colleagues publish a simplified free thyroxine measurement using magnesium precipitation. [50]
- 1970Braverman and colleagues show that people without a thyroid convert T4 to T3. [3]
- 2014The American Thyroid Association names levothyroxine (synthetic T4) the standard treatment for hypothyroidism. [8]
FAQ
What is a normal free T4?
For adults, Labcorp prints 0.82-1.77 ng/dL and Quest 0.8-1.8 ng/dL. Quest's dialysis test uses 0.9-2.2 ng/dL. Children have their own ranges.
What is the difference between free T4 and total T4?
Total T4 counts the hormone bound to carrier proteins as well as the free part. Free T4 has largely replaced it because it is less affected by binding-protein levels.
Sources: [1]
What does a high TSH with a normal free T4 mean?
Subclinical hypothyroidism. European guidance splits it into a mildly raised TSH (4.0-10.0 mU/l) and a higher one (above 10), and repeats TSH and free T4 with thyroid antibodies after 2 to 3 months.
Sources: [17]
What does a low free T4 with a normal TSH mean?
It can point to central hypothyroidism, where the pituitary or hypothalamus does not drive the thyroid. The diagnosis rests on a low free T4 with an inappropriately low TSH.
Sources: [7]
Do I need to stop biotin before a free T4 test?
Yes, if you take high-dose biotin. Labcorp asks you to stop at least 72 hours before; biotin can give falsely high thyroid hormone results that mimic Graves disease.
Is free T4 different in pregnancy?
Yes. Quest's dialysis test prints trimester ranges: 0.9-2.0 ng/dL in the first, 0.8-1.5 in the second and 0.8-1.7 in the third. The American Thyroid Association updated its pregnancy guideline in 2026.
Does free T4 change with age?
In children, yes: newborns run much higher. In adults, a Dutch study of 2.2 million requests found the upper limit rising from age 70.
Do growth hormone peptides lower free T4?
Growth hormone itself can: it speeds T4-to-T3 conversion, and European guidance checks for central hypothyroidism after growth hormone is started in pituitary disease. Single doses of Sermorelin and Hexarelin did not change free T4, and MK-677 (Ibutamoren) courses left total T4 unchanged.
Do semaglutide tablets affect thyroid medicine?
Yes. Taken with semaglutide tablets, levothyroxine exposure (total thyroxine AUC) rose 33%, so the label advises monitoring thyroid tests.
Sources: [16]
Which peptides lower free T4?
Octreotide and Lanreotide, mainly in TSH-secreting pituitary tumors: on lanreotide, free T4 fell from 37.9 to 19.7 pmol/L over 6 months. The octreotide labels also report occasional hypothyroidism on long-term use.
Do GLP-1 drugs like semaglutide or tirzepatide cause thyroid cancer?
Their labels carry a boxed warning: Semaglutide, Tirzepatide, Liraglutide and Dulaglutide caused thyroid C-cell tumors in rodents, and it is unknown whether they do in humans. They must not be used with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. MTC starts in the C-cells, which make calcitonin rather than thyroid hormone, so a thyroid hormone test does not screen for it; the labels add that routine calcitonin or ultrasound monitoring is of uncertain value.
Why do some labs report free T4 in pmol/L?
pmol/L is the SI unit used outside the US. Multiply pmol/L by 0.077688 to get ng/dL.
Sources: [12]
References
- Quest Diagnostics. Test code 866: T4, Free (FT4). Test directory: methodology, clinical significance, reference ranges by age and LOINC. testdirectory.questdiagnostics.com/test/test-detail/866/t4-free-ft4?cc=PHP
- Labcorp. Test 001974: Thyroxine (T4), Free, Direct. Use, special instructions, limitations, specimen requirements, patient preparation, reference range by age and LOINC map. labcorp.com/tests/001974/thyroxine-t4-free-direct
- Braverman LE, Ingbar SH, Sterling K. Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest. 1970;49(5):855-64. PMID 4986007
- Quest Diagnostics. Test code 7444: Thyroid Panel with TSH. Test directory: components, clinical significance and LOINC. testdirectory.questdiagnostics.com/test/test-detail/7444/thyroid-panel-with-tsh?cc=PHP
- Kaplan MM, Taft JA, Reichlin S, et al. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. J Clin Endocrinol Metab. 1986;63(4):808-14. PMID 3091628
- Golstein J, Glinoer D, Bonnyns M, et al. Thyroidal release after oral administration of TRH in normal subjects. J Endocrinol Invest. 1983;6(5):385-7. PMID 6420459
- Persani L, Brabant G, Dattani M, et al. 2018 European Thyroid Association (ETA) Guidelines on the Diagnosis and Management of Central Hypothyroidism. Eur Thyroid J. 2018;7(5):225-237. PMID 30374425
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751. PMID 25266247
- Jørgensen JO, Møller J, Laursen T, et al. Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clin Endocrinol (Oxf). 1994;41(5):609-14. PMID 7828350
- Yamauchi I, Sakane Y, Yamashita T, et al. Effects of growth hormone on thyroid function are mediated by type 2 iodothyronine deiodinase in humans. Endocrine. 2018;59(2):353-363. PMID 29274063
- Quest Diagnostics. Test code 35167: T4, Free, Direct Dialysis. Test directory: methodology, reference ranges (including pregnancy by trimester) and LOINC. testdirectory.questdiagnostics.com/test/test-detail/35167/t4-free-direct-dialysis?cc=PHP
- Moran C, Schoenmakers N, Halsall D, et al. Approach to the Patient With Raised Thyroid Hormones and Nonsuppressed TSH. J Clin Endocrinol Metab. 2024;109(4):1094-1108. PMID 37988295
- Jansen HI, Dirks NF, Hillebrand JJ, et al. Age-Specific Reference Intervals for Thyroid-Stimulating Hormones and Free Thyroxine to Optimize Diagnosis of Thyroid Disease. Thyroid. 2024;34(11):1346-1355. PMID 39283820
- Bi C, Schindler EI, Li EM, et al. Free T4 Age-Specific Reference Intervals from Birth to the 10th Decade of Life Using Direct Dialysis. Thyroid. 2025;35(12):1453-1457. PMID 41196035
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. PMID 27521067
- RYBELSUS and OZEMPIC (semaglutide) tablets, prescribing information. DailyMed. Boxed warning; drug interactions and clinical pharmacology (levothyroxine). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=27f15fac-7d98-4114-a2ec-92494a91da98
- Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism. Eur Thyroid J. 2013;2(4):215-28. PMID 24783053
- Glynn N, Kenny H, Quisenberry L, et al. The effect of growth hormone replacement on the thyroid axis in patients with hypopituitarism: in vivo and ex vivo studies. Clin Endocrinol (Oxf). 2017;86(5):747-754. PMID 27809356
- Kuhn JM, Arlot S, Lefebvre H, et al. Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide. J Clin Endocrinol Metab. 2000;85(4):1487-91. PMID 10770186
- SANDOSTATIN (octreotide acetate) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4e2c9856-1836-49f0-9472-4dbeeb408f39
- Kluge M, Riedl S, Uhr M, et al. Ghrelin affects the hypothalamus-pituitary-thyroid axis in humans by increasing free thyroxine and decreasing TSH in plasma. Eur J Endocrinol. 2010;162(6):1059-65. PMID 20423986
- Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med. 2004;351(10):987-97. PMID 15342807
- Urwyler SA, Lustenberger S, Drummond JR, et al. Effects of oral macimorelin on copeptin and anterior pituitary hormones in healthy volunteers. Pituitary. 2021;24(4):555-563. PMID 33615399
- Markantes GK, Daoussis D, Mamali I, et al. Differences in thyroid function tests after administration of a single supraphysiological dose of ACTH or a high dose of a synthetic steroid. Steroids. 2022;182:109009. PMID 35283116
- Bános C, Takó J, Salamon F, et al. Effect of ACTH-stimulated glucocorticoid hypersecretion on the serum concentrations of thyroxine-binding globulin, thyroxine, triiodothyronine, reverse triiodothyronine and on the TSH-response to TRH. Acta Med Acad Sci Hung. 1979;36(4):381-94. PMID 233400
- Gancel A, Vuillermet P, Legrand A, et al. Effects of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf). 1994;40(3):421-8. PMID 8187308
- Beck-Peccoz P, Mariotti S, Guillausseau PJ, et al. Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 1989;68(1):208-14. PMID 2491862
- Mannavola D, Persani L, Vannucchi G, et al. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism. Clin Endocrinol (Oxf). 2005;62(2):176-81. PMID 15670193
- Sencar ME, Sakiz D, Calapkulu M, et al. The Effect of Exenatide on Thyroid-Stimulating Hormone and Thyroid Volume. Eur Thyroid J. 2019;8(6):307-311. PMID 31934556
- Tee SA, Tsatlidis V, Razvi S. The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes. Clin Endocrinol (Oxf). 2023;99(4):401-408. PMID 36843143
- Köseoğlu D, Özdemir Başer Ö, Berker D, et al. EXENATIDE TREATMENT REDUCES THYROID GLAND VOLUME, BUT HAS NO EFFECT ON THE SIZE OF THYROID NODULES. Acta Endocrinol (Buchar). 2020;16(3):275-279. PMID 33363646
- Laron Z, Frenkel J, Gil-Ad I, et al. Growth hormone releasing activity by intranasal administration of a synthetic hexapeptide (hexarelin). Clin Endocrinol (Oxf). 1994;41(4):539-41. PMID 7955465
- Foulk RA, Musci TJ, Schriock ED, et al. Does human chorionic gonadotropin have human thyrotropic activity in vivo? Gynecol Endocrinol. 1997;11(3):195-201. PMID 9209900
- Hanew K, Tanaka A. Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS). J Endocrinol Invest. 2001;24(1):1-7. PMID 11227726
- Shetty GK, Matarese G, Magkos F, et al. Leptin administration to overweight and obese subjects for 6 months increases free leptin concentrations but does not alter circulating hormones of the thyroid and IGF axes during weight loss induced by a mild hypocaloric diet. Eur J Endocrinol. 2011;165(2):249-54. PMID 21602313
- Massart F, Harrell JC, Federico G, et al. Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty. J Adolesc Health. 2007;40(3):252-7. PMID 17321426
- Guo N, Zhou F, Jiang X, et al. The effect of gonadotropin-releasing hormone analog treatment on the endocrine system in central precocious puberty patients: a meta-analysis. J Pediatr Endocrinol Metab. 2024;37(3):197-208. PMID 38235550
- Ye J, Xu J, Wen W, et al. Effect of Liraglutide on Serum TSH Levels in Patients with NAFLD and its Underlying Mechanisms. Int J Clin Pract. 2022;2022:1786559. PMID 36311486
- Codner E, Cassorla F, Tiulpakov AN, et al. Effects of oral administration of ibutamoren mesylate, a nonpeptide growth hormone secretagogue, on the growth hormone-insulin-like growth factor I axis in growth hormone-deficient children. Clin Pharmacol Ther. 2001;70(1):91-8. PMID 11452249
- Chapman IM, Pescovitz OH, Murphy G, et al. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults. J Clin Endocrinol Metab. 1997;82(10):3455-63. PMID 9329386
- Barron JL, Coy DH, Millar RP. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men. Peptides. 1985;6(3):575-7. PMID 2866496
- De Rosa G, Corsello SM, Della Casa S, et al. Effect of somatostatin on the pituitary-thyroid axis. Ann Endocrinol (Paris). 1983;44(6):355-60. PMID 6146290
- Tomoda F, Takata M, Izumino K, et al. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia. Nephron. 1994;66(3):307-11. PMID 8190183
- Yeksan M, Tamer N, Cirit M, et al. Effect of recombinant human erythropoietin (r-HuEPO) therapy on plasma FT3, FT4, TSH, FSH, LH, free testosterone and prolactin levels in hemodialysis patients. Int J Artif Organs. 1992;15(10):585-9. PMID 1428205
- Carlson HE, Graber ML, Gelato MC, et al. Endocrine effects of erythropoietin. Int J Artif Organs. 1995;18(6):309-14. PMID 8593965
- Dayel FFB, Alanazi RJ, Alenazi MA, et al. Impact of Semaglutide as Weight Management Medication on Clinical Parameters and Health-Related Quality of Life: A Single-Center Study from Saudi Arabia. Healthcare (Basel). 2026;14(7). PMID 41975849
- Somatuline Depot (lanreotide). FDA prescribing information. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6e4a41fd-a753-4362-87ee-8cc56ed3660d
- MYCAPSSA (octreotide) delayed-release capsules, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=58d80bc6-bdfb-4908-93e7-aace447c8d1a
- STERLING K, HEGEDUS A. Measurement of free thyroxine concentration in human serum. J Clin Invest. 1962;41(5):1031-40. PMID 13916968
- Sterling K, Brenner MA. Free thyroxine in human serum: simplified measurement with the aid of magnesium precipitation. J Clin Invest. 1966;45(1):153-63. PMID 4158931
- Korevaar TIM, Leung AM, Alexander EK, et al. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. Thyroid. 2026;36(5):481-544. PMID 42219800
- Wegovy (semaglutide) injection 2.4 mg. FDA prescribing information, Table 10 (cardiometabolic parameters, Study 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- MOUNJARO (tirzepatide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0
- Zepbound (tirzepatide) injection. FDA prescribing information, Table 3 (cardiometabolic parameters, Studies 1 and 2). dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b
- VICTOZA (liraglutide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a9ef4ea-c76a-4d34-a604-27c5b505f5a4
- TRULICITY (dulaglutide) injection, prescribing information. DailyMed. dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309
- Wells SA, Asa SL, Dralle H, et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. Thyroid. 2015;25(6):567-610. PMID 25810047
Educational information, not medical advice. Lab ranges and test codes were checked on November 3, 2026. Always use the range printed on your own report, and talk to a clinician about your results.